Observe Medical – CFO resignation

Oslo, March 21, 2024 - Observe Medical ASA (the "Company" or "Observe Medical") announces that Per Arne Nygård has resigned from his position as CFO in order to pursue opportunities outside of the Company.

Johan Fagerli, the current Finance Manager, will assume the responsibilities of Interim CFO effective immediately. Mr. Fagerli has been with the Company since 2021 and brings extensive experience and a deep understanding of our financial operations, ensuring a smooth transition and continued strategic financial management.

We look forward to Mr. Fagerli's leadership in his new role as we continue to execute our strategic objectives.

For further information, please contact:

Jørgen Mann, Interim CEO Observe Medical
Mobile: +45 408 67 558
E-mail: [email protected]

Johan Fagerli, Finance Manager Observe Medical
Mobile: +47 958 12 765
E-mail: [email protected]

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care, in combination with targeted M&A.

The Company is headquartered in Oslo, Norway, with additional offices in Narvik, Norway and Gothenburg, Sweden, and subsidiaries in Finland and the US. In addition, Observe Medical has a direct sale organization in the Nordics and a distributor network internationally.

Further information is available at www.observemedical.com.